Viral Infections Causing Mouth Ulcers in Pediatric Patients
Herpes Simplex Virus (HSV) is the most common viral cause of oral ulcers in children, presenting as primary gingivostomatitis with painful superficial ulcers in the gingival and oral mucosa 1.
Primary Viral Causes
Herpes Simplex Virus (HSV-1 and HSV-2)
The most frequent viral culprit for oral ulceration in the pediatric population is HSV, particularly outside the neonatal period 1. The clinical presentation includes:
- Primary HSV gingivostomatitis: Characterized by fever, irritability, tender submandibular lymphadenopathy, and superficial painful ulcers in the gingival and oral mucosa and perioral area 1
- Neonatal HSV: Can manifest as disease localized to skin, eyes, and mouth in approximately 40% of neonates, typically appearing at 10-11 days of age 1
- In immunocompromised children (particularly HIV-infected), HSV can cause severe ulcerative disease with frequent recurrences, with 5-10% of children with AIDS and primary gingivostomatitis developing recurrent episodes 1
Studies confirm HSV's predominance: one investigation of oral ulcers in pediatric oncology patients found that 60% (12 of 20 ulcers) were HSV-positive 2, and another study reported HSV type 1 infections accounted for 9.3% of all oral mucosal lesions in children 3.
Other Viral Pathogens
Varicella-Zoster Virus (VZV): Can cause oral lesions during primary infection (chickenpox) or reactivation (shingles) 4. The virus produces vesicular lesions that rupture to form ulcers.
Enteroviruses: Including Coxsackievirus, which causes:
- Herpangina: Characterized by vesicles and ulcers typically on the soft palate and posterior pharynx 5, 4
- Hand-foot-and-mouth disease: Presents with oral ulcers along with characteristic skin lesions 5, 6
Epstein-Barr Virus (EBV): Causes infectious mononucleosis, which can present with oral ulceration, pharyngitis, and palatal petechiae 4.
Cytomegalovirus (CMV): Particularly in immunocompromised children, can cause oral ulceration 7.
Clinical Approach
Diagnostic Clues by Presentation
For HSV gingivostomatitis, look for:
- Multiple painful ulcers with vesicles
- Gingival and oral mucosa involvement
- Perioral distribution
- Fever and submandibular lymphadenopathy
- Typical age: young children with primary infection 1
For immunocompromised patients (HIV, chemotherapy, transplant):
- Consider HSV first, as it causes more severe and prolonged disease 1, 2
- HSV ulcers may be atypical, larger, and slower to heal
- Multiple pathogens may coexist (HSV with Candida) 2
Diagnostic Confirmation
Clinical diagnosis is often sufficient for typical HSV gingivostomatitis based on vesicle and ulcer appearance 1. However, when confirmation is needed:
- Viral culture: Can detect HSV within 1-3 days 1
- PCR: Most sensitive method, particularly for HSV DNA detection 1
- Direct immunofluorescence: Can identify HSV antigen from lesion scrapings 1
Important caveat: Tzanck preparation showing multinucleated giant cells does not differentiate HSV from VZV and is not routinely recommended 1.
Management Priorities
For HSV infections, acyclovir is the drug of choice regardless of HIV status 1, 8:
- Moderate to severe gingivostomatitis: Acyclovir 5-10 mg/kg IV three times daily, then switch to oral when lesions regress 8
- Mild symptomatic gingivostomatitis: Acyclovir 20 mg/kg (max 400 mg/dose) orally three times daily for 5-10 days 8
- Neonatal skin/eye/mouth disease: Acyclovir 20 mg/kg IV three times daily for 14 days 8
Critical consideration: In immunocompromised children, HSV can disseminate or cause severe local disease requiring aggressive IV therapy 1. Early recognition and treatment are essential to prevent morbidity and mortality.
Common Pitfalls to Avoid
Don't dismiss recurrent oral ulcers in HIV-infected children: These may represent HSV reactivation requiring suppressive therapy rather than simple aphthous ulcers 1
Don't confuse HSV with other causes: While HSV is most common, consider enteroviral infections (herpangina, hand-foot-mouth disease) based on distribution pattern—posterior pharynx suggests enterovirus, anterior oral cavity suggests HSV 5, 4
Don't delay treatment in immunocompromised patients: Waiting for culture results can allow progression to disseminated disease 1
Consider mixed infections: In oncology patients, 20% had both HSV and Candida, requiring dual therapy 2